CRF is detectable in bowel tissue following trauma and is significantly lower in trauma vs elective surgery patients, while CRF in blood may be a factor associated with gut barrier changes following shock and emergency laparotomy.
Dr. Vale discovered CRF in 1981 and the next year found a second hormone, called the growth hormone releasing factor, or GRF, which had also eluded the older scientists.
Therefore it is useful to estimate the CRF in a camera-independent way.
Converging findings support a role for extra-hypothalamic CRF in the mediation of the stress response.
Extensive literature suggests a role of CRF in alcohol use disorder (AUD).
This is the first evidence for a role of CRF in adolescent erectile response.
Future research is required to determine whether lower CRF in patients with CHD confers a greater risk of developing CHF.
One of the main difficulties in estimating the CRF in a noise-robust way is that it is required that the weighting function is known.
In this study, CRF in Wistar rats was induced by fed with 0.75% adenine and diosgenin was treated everyday at the dose of 40 mg/kg.
This study was designed to determine whether these amino acid neurotransmitters are colocalized with CRF in terminals within the LC/peri-LC region in the rat.
This study was designed to evaluate the therapeutic or preventive potential of pyridoxamine (PM) against CRF in a 5/6 subtotal nephrectomy rat model.
